Josh Jennings
Stock Analyst at TD Cowen
(2.40)
# 2,929
Out of 4,442 analysts
1090
Total ratings
43.4%
Success rate
0.6%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterated: Buy | $61 | $45.60 | +33.77% | 77 | Jun 22, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $5.5 | $3.91 | +40.66% | 32 | Jun 18, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $95 → $100 | $87.01 | +14.93% | 51 | Jun 18, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | $6 | $7.67 | -21.77% | 32 | Jun 18, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1.5 → $1.25 | $0.7004 | +78.47% | 46 | Jun 17, 2026 | |
| VCEL Vericel | Reiterated: Buy | $55 | $40.39 | +36.17% | 23 | Jun 10, 2026 | |
| DXCM DexCom | Reiterated: Buy | $75 → $95 | $68.92 | +37.84% | 38 | Jun 10, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | n/a | $90.53 | - | 70 | Jun 9, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | n/a | $6.04 | - | 13 | Jun 9, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $29 | $18.39 | +57.69% | 23 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $119 | $80.63 | +47.59% | 69 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 | $86.95 | +19.61% | 70 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $20.60 | +65.05% | 30 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $163 | $143.92 | +13.26% | 21 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.59 | +93.05% | 36 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $14.12 | +77.05% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $20.10 | -0.50% | 36 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.75 | +185.71% | 29 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $73.83 | +62.54% | 67 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.04 | +271.29% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $10.28 | +45.91% | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $4.76 | +110.08% | 29 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $239.08 | +4.57% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $20 | $8.50 | +135.29% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $143.90 | +163.38% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 | $310.00 | +40.32% | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.19 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $6.04 | -0.62% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.41 | +38.79% | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $99 | $87.57 | +13.05% | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.329 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.429 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25.49 | $9.26 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $13 | $1.03 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $125.05 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $1.38 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.0001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $0.128 | n/a | 1 | Mar 18, 2015 |
Boston Scientific
Jun 22, 2026
Reiterated: Buy
Price Target: $61
Current: $45.60
Upside: +33.77%
AVITA Medical
Jun 18, 2026
Reiterated: Buy
Price Target: $5.5
Current: $3.91
Upside: +40.66%
Establishment Labs Holdings
Jun 18, 2026
Rated: Buy
Price Target: $95 → $100
Current: $87.01
Upside: +14.93%
Butterfly Network
Jun 18, 2026
Maintained: Buy
Price Target: $6
Current: $7.67
Upside: -21.77%
Humacyte
Jun 17, 2026
Reiterated: Buy
Price Target: $1.5 → $1.25
Current: $0.7004
Upside: +78.47%
Vericel
Jun 10, 2026
Reiterated: Buy
Price Target: $55
Current: $40.39
Upside: +36.17%
DexCom
Jun 10, 2026
Reiterated: Buy
Price Target: $75 → $95
Current: $68.92
Upside: +37.84%
Abbott Laboratories
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $90.53
Upside: -
Senseonics Holdings
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $6.04
Upside: -
CeriBell
Jun 8, 2026
Reiterated: Buy
Price Target: $29
Current: $18.39
Upside: +57.69%
Jun 4, 2026
Reiterated: Buy
Price Target: $119
Current: $80.63
Upside: +47.59%
Jun 3, 2026
Reiterated: Buy
Price Target: $104
Current: $86.95
Upside: +19.61%
Jun 1, 2026
Reiterated: Buy
Price Target: $34
Current: $20.60
Upside: +65.05%
May 29, 2026
Reiterated: Hold
Price Target: $163
Current: $143.92
Upside: +13.26%
May 27, 2026
Reiterated: Buy
Price Target: $5
Current: $2.59
Upside: +93.05%
May 27, 2026
Reiterated: Buy
Price Target: $25
Current: $14.12
Upside: +77.05%
May 18, 2026
Maintained: Hold
Price Target: $20
Current: $20.10
Upside: -0.50%
May 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.75
Upside: +185.71%
May 13, 2026
Maintained: Buy
Price Target: $120
Current: $73.83
Upside: +62.54%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $4.04
Upside: +271.29%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $10.28
Upside: +45.91%
May 8, 2026
Rated: Buy
Price Target: $12 → $10
Current: $4.76
Upside: +110.08%
Apr 23, 2026
Maintained: Buy
Price Target: $250
Current: $239.08
Upside: +4.57%
Jan 23, 2026
Maintained: Buy
Price Target: $27 → $20
Current: $8.50
Upside: +135.29%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $143.90
Upside: +163.38%
Nov 13, 2025
Maintained: Buy
Price Target: $435
Current: $310.00
Upside: +40.32%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.19
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: $6
Current: $6.04
Upside: -0.62%
Nov 6, 2025
Maintained: Buy
Price Target: $20
Current: $14.41
Upside: +38.79%
Nov 5, 2025
Maintained: Hold
Price Target: $104 → $99
Current: $87.57
Upside: +13.05%
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.329
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.429
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $25.49
Current: $9.26
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $15 → $13
Current: $1.03
Upside: n/a
Oct 29, 2020
Maintained: Buy
Price Target: $80
Current: $125.05
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $1.38
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.0001
Upside: n/a
Mar 18, 2015
Maintained: Buy
Price Target: $9
Current: $0.128
Upside: n/a